Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.79 USD | -16.72% |
|
+5.68% | -81.33% |
06-14 | CareMax, Inc. Appoints Paul Rundell as Chief Restructuring Officer | CI |
05-15 | CareMax, Inc. Enters into a Limited Waiver and Fourth Amendment to Credit Agreement | CI |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 280.3 | 668.7 | 404.8 | 55.97 | 10.61 | - | - |
Enterprise Value (EV) 1 | 280.3 | 738 | 594.1 | 376.3 | 436.4 | 566.4 | 10.61 |
P/E ratio | - | -59.1 x | -8.69 x | -0.08 x | -0.07 x | -0.14 x | -0.23 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | 2.33 x | 1.66 x | 0.64 x | 0.07 x | 0.01 x | 0.01 x | 0.01 x |
EV / Revenue | 2.33 x | 1.83 x | 0.94 x | 0.5 x | 0.49 x | 0.53 x | 0.01 x |
EV / EBITDA | - | 55.4 x | 27 x | -5.97 x | -10.3 x | -168 x | 0.31 x |
EV / FCF | - | -26.5 x | -7.85 x | -6.12 x | 218 x | -11 x | 1.86 x |
FCF Yield | - | -3.77% | -12.7% | -16.4% | 0.46% | -9.08% | 53.7% |
Price to Book | - | 1.33 x | 0.66 x | 0.91 x | -0.17 x | -0.1 x | - |
Nbr of stocks (in thousands) | 599 | 2,902 | 3,697 | 3,745 | 3,803 | - | - |
Reference price 2 | 468.0 | 230.4 | 109.5 | 14.95 | 2.790 | 2.790 | 2.790 |
Announcement Date | 21-03-08 | 22-03-08 | 23-03-09 | 24-03-18 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | 120.4 | 403.3 | 631.1 | 751.1 | 891.9 | 1,071 | 1,128 |
EBITDA 1 | - | 13.32 | 22 | -63.05 | -42.3 | -3.37 | 34.2 |
EBIT 1 | - | -4.262 | 0.315 | -90.84 | -88.9 | -37.79 | -15.1 |
Operating Margin | - | -1.06% | 0.05% | -12.09% | -9.97% | -3.53% | -1.34% |
Earnings before Tax (EBT) 1 | - | -6.516 | -57.34 | -684.2 | -171.1 | -117.3 | -80.9 |
Net income 1 | 7.601 | -6.675 | -37.8 | -683.3 | -144.1 | -103.3 | -62.3 |
Net margin | 6.31% | -1.66% | -5.99% | -90.98% | -16.15% | -9.64% | -5.52% |
EPS 2 | - | -3.900 | -12.60 | -183.3 | -37.47 | -19.31 | -12.18 |
Free Cash Flow 1 | - | -27.85 | -75.67 | -61.52 | 2 | -51.45 | 5.7 |
FCF margin | - | -6.91% | -11.99% | -8.19% | 0.22% | -4.8% | 0.51% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | 16.67% |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - | - |
Announcement Date | 21-03-08 | 22-03-08 | 23-03-09 | 24-03-18 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 118.3 | 136.9 | 172.3 | 157.7 | 164.3 | 173 | 224.4 | 201.8 | 151.8 | 232.2 | 230 | 212.8 | 201.4 | 254.9 | 300.2 |
EBITDA 1 | 4.257 | 5.862 | 9.374 | 9.224 | 5.124 | -0.061 | 7.042 | 2.077 | -72.11 | -10.48 | -11.8 | -11.4 | -8.7 | -4.8 | 0.1 |
EBIT 1 | -1.832 | 0.8 | 4.471 | 4.651 | -2.056 | -6.637 | -3.75 | -90.77 | -79.66 | -17.19 | -23.6 | -23.2 | -20.5 | -15.9 | -11 |
Operating Margin | -1.55% | 0.58% | 2.6% | 2.95% | -1.25% | -3.84% | -1.67% | -44.97% | -52.46% | -7.4% | -10.26% | -10.9% | -10.18% | -6.24% | -3.66% |
Earnings before Tax (EBT) 1 | -3.395 | -16.62 | -9.21 | -21.87 | -9.64 | -81.9 | -32.2 | -102.9 | -467.2 | -43.23 | -43.8 | -43.4 | -40.7 | -29.01 | -28.36 |
Net income 1 | -3.553 | -16.8 | -9.381 | -22.05 | 10.43 | -82.08 | -32.38 | -103.1 | -465.8 | -43.41 | -33.88 | -34.63 | -36.84 | -25.27 | -25.16 |
Net margin | -3% | -12.27% | -5.45% | -13.99% | 6.35% | -47.45% | -14.43% | -51.09% | -306.76% | -18.69% | -14.73% | -16.27% | -18.29% | -9.91% | -8.38% |
EPS 2 | -1.200 | -5.700 | -3.300 | -7.500 | 3.000 | -22.20 | -8.700 | -27.60 | -181.4 | -11.49 | -8.910 | -8.830 | -8.260 | -5.299 | -4.915 |
Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 22-03-08 | 22-05-10 | 22-08-09 | 22-11-09 | 23-03-09 | 23-05-10 | 23-08-09 | 23-11-09 | 24-03-18 | 24-05-09 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | 69.3 | 189 | 320 | 426 | 556 | - |
Net Cash position 1 | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | 5.204 x | 8.607 x | -5.08 x | -10.07 x | -165 x | - |
Free Cash Flow 1 | - | -27.8 | -75.7 | -61.5 | 2 | -51.5 | 5.7 |
ROE (net income / shareholders' equity) | - | -3.85% | -2.41% | -36.8% | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | 174.0 | 167.0 | 16.40 | -16.40 | -27.90 | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | - | 3.99 | 7.45 | 14.6 | 10.5 | 10.7 | 11.3 |
Capex / Sales | - | 0.99% | 1.18% | 1.95% | 1.17% | 1% | 1% |
Announcement Date | 21-03-08 | 22-03-08 | 23-03-09 | 24-03-18 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.33% | 10.61M | |
+18.69% | 84.15B | |
-25.20% | 74.14B | |
+1.62% | 26.92B | |
-10.46% | 17.15B | |
-0.68% | 16.83B | |
-0.73% | 15.21B | |
+76.04% | 12.99B | |
+72.88% | 13.3B | |
+21.31% | 12.38B |
- Stock Market
- Equities
- CMAX Stock
- Financials CareMax, Inc.